483
AGC Biologics A/SAGC Biologics A/S – FDA 483
Record Details
An FDA inspection of AGC Biologics, Inc. in Copenhagen, Denmark, a drug substance manufacturer, revealed two significant observations. The firm failed to ensure adequate personnel training for sample handling operations, leading to high sample failure rates and impacted product quality. Additionally, the inspection noted a lack of timely implementation of change control for test method document updates, resulting in reoccurring deviations.
- Company
- AGC Biologics A/S
- Product type
- drugs
View Company Profile
ID · 95a4aa35-7bbc-4c3e-94c9-a98e3e30da8e
Other documents for AGC Biologics A/S
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.